Alaunos Director Acquires $2.7M in Preferred Stock Through Investment Firm
Insider Trading Activity Report for Alaunos Therapeutics (TCRT) reveals significant transactions by Director Robert W. Postma.
Rhea-AI Filing Summary
Insider Trading Activity Report for Alaunos Therapeutics (TCRT) reveals significant transactions by Director Robert W. Postma. On June 24, 2025, Postma acquired 600 shares of Series A-2 Convertible Preferred Stock at $4.49 per share through WaterMill Asset Management Corp, convertible to 133,630.29 common shares.
Key holdings and transactions include:
- Direct ownership of 29,083 common shares, including recent acquisition of 20,804 shares at $2.92
- Indirect ownership through WaterMill Asset Management Corp of 33,333 common shares
- 500 Series A-1 Preferred Stock (convertible to 181,159 common shares) at $2.76
- Employee Stock Option for 3,737 shares at $10.30, vesting monthly through 2025
Notable ownership restrictions include a 4.99% beneficial ownership limit on converted preferred shares. The filing indicates continued insider investment in the company with diversified security types.
Positive
- Director Robert Postma acquired 20,804 shares of common stock at $2.92 per share, representing a significant open market purchase worth approximately $60,748
- Director Postma purchased 600 Series A-2 Convertible Preferred Stock at $4.49, demonstrating further confidence in the company through substantial investment
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Series A-2 Convertible Preferred Stock | 600 | $4.49 | $3K |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| Grant/Award | Common Stock | 20,804 | $2.92 | $61K |
| Purchase | Series A-1 Convertible Preferred Stock | 500 | $2.76 | $1K |
Footnotes (4)
- F1. The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
- F2. The preferred stock is perpetual and therefore has no expiration date.
- F3. The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance.
- F4. One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider trading activity occurred at TCRT (Alaunos Therapeutics) on June 24, 2025?
What stock options does Robert Postma hold in TCRT?
What convertible preferred stock positions does Robert Postma hold in TCRT through WaterMill Asset Management?
What ownership limitations apply to TCRT's convertible preferred stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.